Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer.

By Mingzhen Zhang, E. Viennois, M. Prasad, Yunchen Zhang, Lixin Wang, Zhan Zhang, Moon K Han, Bo Xiao, Changlong Xu, S. Srinivasan and 1 more. Biomaterials, 2016

875 citations recorded by the source corpus.

Subfields: Immunology, Pharmacology

View Paper: https://www.semanticscholar.org/paper/1860db2a83afe329c26424b8e689d3e866020170

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. R. Gan
2. Huabin Li
3. Qian-Qian Mao
4. Xiao-Yu Xu
5. Shi-Yu Cao
6. H. A. Dad
7. Lu-qi Huang
8. Tingwei Gu

Citations in the corpus

• Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe) (2019, background): “Besides, ginger extract and zingerone inhibited NF-κB activation and decreased the level of IL-1β in the colons of mice, which alleviated colitis induced by 2, 4, 6-trinitrobenzene sulfonic acid [38].”
• Plant exosome like nanovesicles: Emerging therapeutics and drug delivery nanoplatforms. (2020, background): “Additionally, TRAIL-mediated apoptotic cell death, anti-angiogenic actions, and pharmacologically active components of PELNVs also cast a spotlight on their anti-neoplastic actions.(87,112) In addition, owing to elevated permeability and the retention effect, PELNVs tend to lodge inside tumor tissue”